Search Results - clinical+and+disease+specializations+%3e+rheumatology+%3e+osteoarthritis

2 Results Sort By:
Hexosamine Analogs for Regenerative Medicine and Diseases Associated with the Musculoskeletal System
Unmet Need:Osteoarthritis (OA) is the most common form of arthritis, affecting an estimated 32.5 million adults in the United States, with an increasing incidence as the population ages (see CDC) . OA is associated with considerable morbidity as a consequence of joint damage, resulting in pain, loss of joint range of motion, and disability. The disease...
Published: 5/9/2024   |   Inventor(s): Kevin Yarema, Jennifer Elisseeff, Jeannine Coburn, Udayanath Aich
Keywords(s): Antagonists/Inhibitors, Arthritis, Biologics, Carbohydrates, Disease Indication, Drug Delivery Mechanism, Drug Delivery Vehicle, Joint Disorders, Novel, Osteoarthritis, Predicted Novelty, Single, Small Molecules, Targeted Therapy, Therapeutic Matter, Therapeutic Substance, Therapeutics, Therapy Type
Category(s): Clinical and Disease Specializations, Technology Classifications > Therapeutic Modalities > Small Molecules, Technology Classifications > Therapeutic Modalities > Targets, Clinical and Disease Specializations > Rheumatology, Technology Classifications > Therapeutic Modalities, Clinical and Disease Specializations > Rheumatology > Arthritis, Clinical and Disease Specializations > Rheumatology > Osteoarthritis
Prostaglandin E2 Mediates Sensory Nerve for Bone Formation and Pain of Skeletal Diseases
Unmet NeedMore than 50 million US adults are affected by arthritis, a joint disorder that can result in persistent pain. There is no cure for arthritis, and in the end stages of the disease, joint replacement is often needed. Current approaches to treat arthritis aim to control pain via the use of analgesics and nonsteroidal anti-inflammatory drugs...
Published: 5/9/2024   |   Inventor(s): Xu Cao
Keywords(s): Arthritis, Disease Indication, Joint Disorders, Osteoarthritis, Target, Therapeutic Matter, Therapeutics
Category(s): Clinical and Disease Specializations > Rheumatology > Osteoarthritis, Technology Classifications > Therapeutic Modalities > Targets
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum